Fill in your details to get instant access
We respect your privacy. No spam, ever.
This webinar brings together senior pharmacovigilance and drug safety leaders to discuss how organizations can strengthen patient safety through integrated safety strategies, cross-functional collaboration, artificial intelligence, proactive signal detection, and effective risk management. The discussions are designed to provide practical insights, strategic perspectives, and real-world experiences from industry experts.
Explore how artificial intelligence, machine learning, and automated literature screening are transforming signal detection and drug safety workflows. Discussions center on utilizing technology to transition toward continuous risk intelligence.
Address strategic operational frameworks that effectively balance efficiency, high quality, and strict regulatory compliance. Panels evaluate India’s expanding role as a global hub for specialized pharmacovigilance services.
Reimagine risk management plans (RMPs) and risk evaluation frameworks to make sounder benefit-risk decisions. Sessions share actionable practices for maintaining safety throughout a drug’s lifecycle.
Discover practical strategies for integrating Real-World Data (RWD) and Real-World Evidence (RWE) into safety monitoring systems. Experts demonstrate how observational data can enhance signal evaluation and patient outcomes.
Examine evolving global compliance guidelines, combination product safety, and closer collaboration between industry and regulators. Speakers discuss frameworks that support innovative safety oversight.
Focus on vendor oversight, moving from effective CAPAs to a culture of compliance. Discussions outline predictive inspection strategies to address quality risks before formal findings occur.
Fill in your details to get instant access
We respect your privacy. No spam, ever.
42nd Pharmacovigilance India 2026: Shaping the Future of Drug Safety
Welcome to Virtue Insight’s 42nd Pharmacovigilance India 2026, held on July 23, 2026, at the Radisson Hotel Hyderabad Hitec City. As India’s pharmaceutical sector expands globally, maintaining robust safety surveillance is critical. This premier event brings together industry leaders, CROs, and regulatory experts to discuss key developments transforming drug safety. Key focus areas include AI-driven signal detection, automation, real-world evidence (RWE), risk management, and regulatory compliance. Designed for interactive discussion and peer-level networking, the conference offers essential insights into modernizing pharmacovigilance practices, optimizing outsourcing strategies, and strengthening patient safety standards across the global healthcare ecosystem.






















Learn directly from senior industry leaders with extensive hands-on expertise.
Explore cutting-edge frameworks in integrated safety and AI integration.
Implement proven approaches for proactive signal detection and risk minimization.
Connect and exchange ideas with peers across the drug safety lifecycle.
Discover practical approaches for integrating Real-World Evidence (RWE) and Real-World Data (RWD) into core safety workflows. Learn to utilize observational data to refine risk management plans and enhance patient outcomes.
An opportunity to meet and network with your webinar colleagues online.
Unifying Data, AI and Cross-Functional Collaboration to Shape the Future of Patient Safety
10:00 – 11:00 Panel Discussion 1: Integrated Safety in Pharmacovigilance
Moderator
Panellists
11:00 Break
11:15: Panel Discussion 2: From Signal Detection to Risk Management
Moderator
Panellists
12:15 End of Webinar & Closing
10:00: Panel Discussion 1: Integrated Safety in Pharmacovigilance
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
TRANSFORMING PV OUTSOURCING
Moderator
Panellists
RMP – INNOVATION, INSIGHTS, IMPACT
Moderator
Panellists
Speaker TBC
Clinevo Technologies
12:40 – Networking luncheon
GCC IN PHARMA / DIGITAL TRANSFORMATION
Moderator
Panellists
SIGNAL DETECTION
SIGNAL
Pharmacovigilance transformation extends beyond technology adoption and requires effective change management. Aligning internal and external stakeholders through shared objectives, communication and governance which minimizes resistance and supports seamless implementation of new processes and digital innovations. This session explores practical strategies for stakeholder alignment that enable compliant, patient-centric, and sustainable business transformation in PV.
15:00 – Afternoon Coffee/Tea & Networking
GROWING ROLE OF RWE / RWD
Moderator
Panellists
HARMONIZING PV REGULATIONS
Moderator
Panellists
AUDITS / INSPECTION
Speakers
We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 42nd pharmacovigilance india 2026
Registration is free of cost, subject to approval by our event organizer – Virtue Insight.
To register your interest in attending, please email info.uk@virtueinsight.com confirming your name, job title and organization. Our team will revert with confirmation once your registration has been reviewed and approved.
It’s a flagship symposium organized by Virtue Insight & Pivot Path (Demerged Entity of Arcolab) that provides platform for discussion on advancements in pharmacovigilance, changing regulatory expectations, presenting peer case studies, impact of technology on workflows, processes & systems, efficiencies, and scale etc. The program is suitable primarily for PV senior leadership and operational leaders, PV technology providers, PV Quality & PV IT professionals.
The theme at the second edition: Program theme: ‘Changing PV Landscape in India: Elevating Patient Safety, Enabling Strategic Outcomes’
Indian pharmaceutical companies have become the global hub in supply in generic medicines and vaccines. Patient safety has always been of paramount importance in this industry more so as the companies expand its footprint across therapeutic areas and geographies. Indian pharma companies have evolved in pharmacovigilance, transforming it from reactive compliance function into a proactive managed risk function. As global regulations and health authority expectations intensify, PV is finding its place—shaping market entry strategies, portfolio decisions, business development, patient programs, and enterprise-wide compliance vision.
Over the few years, technology-driven transformation has further revolutionized PV operations—boosting compliance, efficiency, and quality, and redefining how organizations safeguard patient safety in a dynamic global landscape.
In the second edition of PV Fusion, we delved upon changing PV landscape in India driven by shifting operational models, expansion to broader and newer therapeutic areas, technology intervention, wide spread talent pool, globalization of Indian companies and localization of MNCs through its GCC etc.
It was very beneficial & effective conference. Got an opportunity to meet members from PV world & learn new areas if AI, Drug Development. Would defiantly visit again if given an opportunity.
A great platform to understand the current practices & situation all across the industry, as well as individual approach of each company toward the goal of patient safety.
I would like to appreciate the efforts & initiative of Virtue Insight in organising the 17th Pharmacovigilance 2018 dedicated conference. The conference was very much interesting & was a good platform for networking, It was well organised, very insightful & a informative conference. The whole conference was more lively & in particular the panel discussions. This should happen regularly to keep PV professional updated. I have enjoyed the whole conference very much.
Had wonderful opportunity to share current challenges with Regulatory aspects of Pharmacovigilance. Very informative conference and very much needed to educated all the stake holders considering current scenario of Pharmacovigilance within our regulatory. We had very interesting discussion on CRO role for end to end Pharmacovigilance. I enjoy the way Dr. Milind handled our Panel discussion.
Very nicely managed. Good Speakers & content. Cooperative and convenient venue. Nice management of time. Good opportunity for networking
The Venue, key speakers included from big pharma companies & CROs has been perfect for the topic of panel discussion
The session was knowledge transfer/sharing and valuable too
A commercial knowledge venture explored several areas under the topic. Very good and Professional speakers.
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Error: Contact form not found.